To explore the potential impact of aberrant serum PTH/calcium/phosphorus levels (individual or combined effects) on the occurrence of PD-related peritonitis, we longitudinally followed up these patients for 60 months and analyzed their peritonitis-free survivals for comparisons. This evidence concerns the gene PTH and peritonitis.